본문 바로가기

Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
PHARMACEUTICS10(4) · 2018
피인용
Web of Science 14Scopus 16
FWCI (Scopus)
0.97
JCR IF
JCR 2017 3.746
ISSN
1999-4923

저자

  1. Kim, Jeong-Soo제1저자Dong-A ST Co. Ltd., Yongin, South Korea
  2. 김민수교신저자College of Pharmacy, Pusan National University, Busan, South Korea
  3. Baek, In-HwanCollege of Pharmacy, Kyungsung University, Busan, South Korea

초록

Tadalafil is an oral selective phosphodiesterase type-5 inhibitor with demonstrated efficacy and safety that is used to treat erectile dysfunction. The purpose of this study is to compare the pharmacokinetic properties of tadalafil after conventional oral tablet administration and novel intranasal administration in beagle dogs. Fourteen 13-month-old male beagle dogs were randomly divided into two groups, and were given 5 mg tadalafil orally or intranasally in a parallel design. Blood samples were collected before and 0.5, 1, 1.5, 2, 4, 6, 8, 12, 24, and 36 h after administration. The plasma concentration of tadalafil was determined via liquid chromatography-tandem mass spectrometry (LC-MS/MS). The systemic exposure and absorption rate of tadalafil were significantly greater in the intranasal administration group than in the oral administration group. A one-compartment model with first-order absorption and elimination was sufficient to explain the pharmacokinetic characteristics observed after both oral and intranasal administration. This study indicates that the development of tadalafil nasal delivery systems is feasible and may lead to better results than the conventional oral route.

키워드

tadalafilpharmacokineticsintranasalmodelingdogERECTILE DYSFUNCTIONIN-VITROORODISPERSIBLE FILMDRUG-DELIVERYSILDENAFILPHARMACOKINETICSFORMULATIONEFFICACYUDENAFILGEL

식별자

Scopus EID
2-s2.0-85056146791
WoS UID
000455853800025